Kreisl TN - Search Results

1

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).

Kreisl TN, Lassman AB, Mischel PS, Rosen N, Scher HI, Teruya-Feldstein J, Shaffer D, Lis E, Abrey LE. Kreisl TN, et al. J Neurooncol. 2009 Mar;92(1):99-105. doi: 10.1007/s11060-008-9741-z. Epub 2008 Nov 19. J Neurooncol. 2009. PMID: 19018475 Clinical Trial.

2

Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma.

Kreisl TN, Panageas KS, Elkin EB, Deangelis LM, Abrey LE. Kreisl TN, et al. Leuk Lymphoma. 2008 Sep;49(9):1710-6. doi: 10.1080/10428190802238560. Leuk Lymphoma. 2008. PMID: 18661394

3

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.

Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS, Fine HA. Kreisl TN, et al. J Clin Oncol. 2009 Feb 10;27(5):740-5. doi: 10.1200/JCO.2008.16.3055. Epub 2008 Dec 29. J Clin Oncol. 2009. PMID: 19114704 Free PMC article. Clinical Trial.

4

Chemotherapy for malignant gliomas.

Kreisl TN. Kreisl TN. Semin Radiat Oncol. 2009 Jul;19(3):150-4. doi: 10.1016/j.semradonc.2009.02.003. Semin Radiat Oncol. 2009. PMID: 19464629

5

Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.

Iwamoto FM, Kreisl TN, Kim L, Duic JP, Butman JA, Albert PS, Fine HA. Iwamoto FM, et al. Among authors: kreisl tn. Cancer. 2010 Apr 1;116(7):1776-82. doi: 10.1002/cncr.24957. Cancer. 2010. PMID: 20143438 Free PMC article. Clinical Trial.

6

A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas.

Kreisl TN, Kotliarova S, Butman JA, Albert PS, Kim L, Musib L, Thornton D, Fine HA. Kreisl TN, et al. Neuro Oncol. 2010 Feb;12(2):181-9. doi: 10.1093/neuonc/nop042. Epub 2010 Jan 22. Neuro Oncol. 2010. PMID: 20150385 Free PMC article. Clinical Trial.

7

Scale to predict survival after surgery for recurrent glioblastoma multiforme.

Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM. Park JK, et al. Among authors: kreisl tn. J Clin Oncol. 2010 Aug 20;28(24):3838-43. doi: 10.1200/JCO.2010.30.0582. Epub 2010 Jul 19. J Clin Oncol. 2010. PMID: 20644085 Free PMC article.

8

Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy.

Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM. Fraum TJ, et al. Among authors: kreisl tn. J Neurooncol. 2011 Nov;105(2):281-9. doi: 10.1007/s11060-011-0579-4. Epub 2011 Apr 27. J Neurooncol. 2011. PMID: 21603965 Free PMC article.

9

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma.

Kreisl TN, Zhang W, Odia Y, Shih JH, Butman JA, Hammoud D, Iwamoto FM, Sul J, Fine HA. Kreisl TN, et al. Neuro Oncol. 2011 Oct;13(10):1143-50. doi: 10.1093/neuonc/nor091. Epub 2011 Aug 24. Neuro Oncol. 2011. PMID: 21865400 Free PMC article. Clinical Trial.

10

Continuous daily sunitinib for recurrent glioblastoma.

Kreisl TN, Smith P, Sul J, Salgado C, Iwamoto FM, Shih JH, Fine HA. Kreisl TN, et al. J Neurooncol. 2013 Jan;111(1):41-8. doi: 10.1007/s11060-012-0988-z. Epub 2012 Oct 20. J Neurooncol. 2013. PMID: 23086433 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters